Mylan Tries To Escape Pharmacy's EpiPen Antitrust Suit

By Meghan Kelly · December 15, 2020, 5:46 PM EST

Mylan Pharmaceuticals has urged a Kansas federal judge to drop it from a suit alleging it inflated the price for the emergency allergy medication EpiPen, arguing the retail and online pharmacy...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Related Sections

Case Information

Case Title

In Re: Epipen (Epinephrine Injection, USP) Marketing, Sales Practices and Antitrust Litigation

Case Number

2:17-md-02785

Court

Kansas

Nature of Suit

Personal Inj. Prod. Liability

Date Filed

August 04, 2017

Case Title

KPH Healthcare Services, Inc. v. Mylan N.V. et al

Case Number

2:20-cv-02065

Court

Kansas

Nature of Suit

Anti-Trust

Date Filed

February 14, 2020

Featured Stories

Biotechs Rev Up To Go Public, Spurring Hope For The Sector No Photo Available

Yeji Jesse Lee

A smattering of biotech companies have signaled plans to go public in recent days, kicking off what industry insiders expect to be a b... (more story)

Doctors Hope Justices Maintain Shield Against Med Mal Suits No Photo Available

Dan McKay

A case headed to the U.S. Supreme Court next week could roll back a legal doctrine that physicians say is key to protecting them from ... (more story)

3 Things To Know About Marine's Abortion Pill Discovery Row No Photo Available

Mark Payne

A Marine pilot accused of duping a Texas woman with whom he had an intimate relationship into taking abortion pills by lacing her drin... (more story)